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Collectins such as surfactant proteins SP-A, SP-D, and mannan-binding lectin (MBL), as well 
as complement protein C1q are evolutionarily conserved innate immune molecules. They are 
known to opsonize a range of microbial pathogens (bacteria, fungi, virus, and parasites) and 
trigger effector clearance mechanisms involving phagocytosis and/or complement activation. 
Collectins and C1q have also attracted attention in studies involving pregnancy as they are 
expressed in the female reproductive tissues during pregnancy; a unique state of immune 
suppression with increased susceptibility to infectious diseases. Recent studies are beginning 
to unravel their functional significance in implantation, placentation, pregnancy maintenance 
and parturition in normal and adverse pregnancies. Collectins and C1q, expressed in 
gestational tissues during pregnancy, might alter the status of mother’s immune response to 
the allogenic fetus and the microenvironment, thereby serving as important regulators of 
fetus-mother interaction.  Here, we discuss the functional roles that have been assigned to SP-























The innate immune system is activated by receptors that recognize pathogen-associated 
molecular patterns (PAMPs) and bring about inflammatory responses, thus acting as 
immunomodulators (Janeway and Medzhitov, 2002). These receptors have the ability to 
distinguish self from non-self molecules by recognizing the specific orientation of hydroxyl 
groups of hexoses (mannose, glucose, fructose and N-acetyl-D-glucosamine) and charge 
patterns, which are present on the surface of microbes (Medzhitov, 2007). This binding 
promotes clearance of pathogens via neutralisation, agglutination, and/or phagocytosis 
(Kawai and Akira, 2010).  
Collectins belong to a family of evolutionarily conserved mammalian pattern 
recognition molecules that are characterized by calcium-dependent (C-type lectin) 
carbohydrate binding domain (Epstein et al., 1996). Its members include surfactant protein A 
and D (SP-A and SP-D), mannose binding lectin (MBL), scavenger receptor collectin 
placenta-1 (CL-P1), collectin liver-1 (CL-L1), collectin kidney-1 (CL-K1), conglutinin, 
collectin of 43 kDa (CL-43), and collectin of 46 kDa (CL-46) (Kishore et al., 2006).  
SP-A, SP-D and MBL are soluble oligomeric proteins. The structural organization of 
SP-A, SP-D and MBL includes four distinct regions: a short cysteine containing N-terminal 
region with disulphide bonds, a proline rich triple-helical collagen region with Gly-X-Y 
repeats, a hydrophobic α-helical coiled coil neck region, and a C-terminal lectin 
/carbohydrate recognition domain (CRD) region (Kishore et al., 2006). The collagen domain 
is known to have receptors on various immune cells including calreticulin-CD91 receptor 
complex (Gardai et al, 2003). Humans contain two highly similar SP-A genes, SPA-1 
(SFTPA-1) with 5 exons and SP-A2 (SFTPA-2) with 6 exons (Katyal et al., 1992; 
McCormick et al., 1994). SP-A is composed of 650 kDa, hexameric structure of six trimers. 
Its collagen domain with 23 Gly-X-Y repeats is interrupted by a kink giving rise to a 
structure resembling a bouquet of tulips (Voss et al., 1988). SP-D appears as a cruciform 
structure due to its tetrameric structure (520 kDa) with 4 trimers (Figure 1) (Crouch et al., 
1994).  
MBL is composed of six 96 kDa trimeric subunits and with bouquet-like structure 
similar to SP-A due to kink interruption within 19 Gly-X-Y repeats. Unlike other collectins, 
MBL can activate the lectin pathway of the complement cascade via MBL associated serine 
proteases (MASPs) (Ji et al., 1997; Thiel  et al., 1997; Thiel, 2007; Degn et al., 2012). MBL2 
gene encoding functional human MBL protein has 3 single nucleotide polymorphisms (SNPs) 
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at codon 52 (variant D-alelle, Arg52 Cys), codon 54 (Variant B-allele, Gly54 Asp) and codon 
57 (Variant C allele, Gly57 Glu). SNPs within the MBL2 at codon 54 consist of two variants: 
allele A (wild type) and allele B (Madsen et al, 1994; Madsen et al, 1995). SP-A, SP-D and 
MBL have been extensively shown to involved in innate immune anti-microbial defence via a 
range of mechanisms including modulation of adaptive immunity, and thus, feature centrally 
in the regulation of inflammation.  
Complement component C1q (460 kDa) is the first subcomponent of the complement 
classical pathway with three polypeptide chains (A, B and C). The A, B and C chains 
comprise of N terminal domain with cysteine residues, a collagen-like region (CLR), and a 
C-terminal globular domain (gC1q) (Sellar et al., 1992). C1q is involved in innate host 
defence and several modulatory process including pathogen clearance, apoptosis, 
angiogenesis, chemotaxis, cell differentiation, adhesion, migration, coagulation via platelets, 
autoimmunity, isotype switching, tolerance (Kishore et al., 2004).  
The human genes for SP-A, SP-D and MBL are located on the long arm of 
chromosome 10 between 10q21-24 (Crouch et al., 1993). All three A, B and C chains of 
human C1q are located on chromosome 1p34.1-1p36.3 (Sellar et al., 1992) (Table 1). The 
ciliated alveolar epithelial type II pneumocytes and non-ciliated bronchial Clara cells in lungs 
are the major source of SP-A and SP-D (Ballard et al., 1986; Persson et al., 1988). Unlike 
most of the collectins largely synthesized by lungs, MBL and C1q are synthesized in the liver 
(Kawasaki et al., 1978). However, extra-pulmonary and extra-hepatic biosynthesis of 
collagens have been reported (Table 2). Using RT-PCR, expression of SP-A, SP-D, MBL and 
C1q transcripts have also been shown in salivary glands, lacrymal glands (Madsen et al., 
2003), pancreas, bile ducts, thymus, prostate (Madsen et al., 2000), colon (Eliakim et al., 
1997), small and large intestine (Uemura et al., 2002), brain, spleen (Wagner et al., 2003), 
Kidney (Ezekowitz et al., 1988), epithelial cells, mesenchymal cells (Morris et al., 1978), 
dendritic cells (Vegh et al., 2003), microglial cells (Farber et al., 2009) (Table 2).  
The roles of collectins and C1q are not solely restricted to recognition and elimination 
of pathogens. Evidence clearly demonstrates that these soluble defence collagens are at the 
crossroads of both innate and adaptive immunity as they regulate inflammation, host-
pathogen interaction, immune tolerance and offer immune protection at multiple levels. 
Furthermore, their deficiency and dysregulated expression has been associated with 
infectious diseases. An intriguing feature of collectins (SP-A, SP-D, and MBL) is that they 
exhibit dual immunological function (pro-inflammatory and anti-inflammatory) based on 
their interaction with candidate receptors, SIRP-α and calreticulin/CD91 (Gardai et al., 
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2003). Recent studies have highlighted the importance of these soluble proteins in novel 
functions related to maintenance of pregnancy (implantation, vascular remodeling, and 
placental formation) and parturition. Here, we discuss collectins and C1q with respect to their 
cellular sources, their expression in the female reproductive system, and their roles in 
pregnancy and parturition.  
 
Expression of collectins and C1q in the female reproductive system 
Peripheral blood and serum  
During pregnancy, no significant changes can be observed in the levels of SP-A in maternal 
serum before (7-74 ng/ml) or after labor (9.6-73.6 ng/ml) (Cho et al., 1999). The 
concentration of serum MBL in various individuals varies depending on the SNPs in the 
promoter region and the coding region (exon-1) of the MBL-2 gene (Bodamer et al., 2006). 
The structural mutation in exon-1 (encoding a single polypeptide region, a cysteine rich 
region and a part of collagen region) of the MBL-2 gene has been proposed to impair higher 
oligomer formation preventing the functional ability of MBL to activate the complement 
lectin pathway via MASPs (Matsushita et al., 1995; Terai et al., 2003; Roos et al., 2003). It 
may be concluded that polymorphisms in the promoter region significantly decrease the 
serum MBL level, and hence, very little amount of higher oligomeric forms of MBL can be 
observed in serum when compared to trimeric and tetrameric forms. During pregnancy, MBL 
genotypes and polymorphisms correlate with the serum concentration of MBL. Hence, serum 
levels of MBL increase in the first trimester and then decrease in the 6
th
 week post-partum 
(van de Geijn et al., 2007a). In another study, levels of MBL in the peripheral blood remain 
relatively constant throughout pregnancy in all three trimesters and at delivery, but decreases 
sharply after delivery (Thevenon et al., 2009).  
C1q levels in normal pregnancies were significantly lower than in non-pregnant 
women, and levels in spontaneous abortions were significantly higher than in normal 
pregnancies. Furthermore, it has been shown that artificial and spontaneous abortions can be 
prevented by treatment, which decreases C1q levels within 7 days (Saitoh et al., 1983). 
 
Non-pregnant female reproductive tract  
Maternal endometrium undergoes cyclic changes regulated by steroid hormones during the 
menstrual cycle that directs the differentiation of endometrial epithelial and stromal cells 
crucial for uterine receptivity and implantation for pregnancy (Kannan et al., 2010). The first 
direct demonstration of SP-D mRNA and protein expression in the uterus suggested the 
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possible roles and significance of collectins in innate host defense against pathogens (Madsen 
et al., 2000).  Protein and mRNA expression of SP-A and SP-D have been observed in the 
female vagina, uterus, ovary, cervix, and oviduct (Table 2, Figure 2) (Akiyama et al., 2002; 
Oberley et al., 2004; Leth-Larsen et al., 2004). In humans, a strong expression of SP-D in the 
epithelium of the endometrial glands is observed that increases towards the secretory phase of 
regular menstrual cycle compared to the proliferative phase (Leth-Larsen et al., 2004). In 
mouse uterus, SP-D has shown to be hormonally regulated, with peak levels present at estrus, 
which then decreases at diestrus (Kay et al., 2015). Ovariectomised mice showed 
significantly reduced expression of SP-D in uteri; following treatment with estrogen and 
progesterone, SP-D expression increased nine-fold (Kay et al, 2015). Further, treatment with 
progesterone during diestrus reduced the level of SP-D making them vulnerable to infection 
(Oberley et al., 2007).  
SP-A is reported to be expressed by both pre-and post-menopausal vaginal stratified 
squamous epithelium and vaginal lavage fluid (MacNeill et al., 2004). Using 
immunohistochemistry, SP-A expression within the glandular and stromal cells has been 
observed in the maternal endometrium during the early proliferative phase (day 6-7) of the 
menstrual cycle. The levels of MBL in the vaginal epithelial cells vary in a cycle-dependent 
manner with greater changes occurring in the secretory phase of the menstrual cycle. This 
change, which is associated with progesterone, implicates the protective role of MBL in the 
female genital tract (Bulla et al., 2010). These findings strongly suggest that cyclic variations 
in SP-A, SP-D and MBL expression are hormonally regulated.   
 
Amniotic fluid and umbilical cord 
Amniotic fluid (AF) is in constant contact with the fetus throughout pregnancy. It protects 
and supports fetal development (Underwood et al., 2005). Secretions of soluble immune 
factors from the fetal lungs travel into the AF (Condon et al., 2004), which is likely to have 
anti-microbial functions (Underwood et al., 2005). SP-A and SP-D are detected in the AF 
during the mid-pregnancy and their concentrations significantly increases with advancing 
gestational age reaching maximum at term (ranging between 1.2 and 15 µg/ml) (Miyamura et 
al., 1994). SP-D level gradually increases from 0.11 µg/ml (14-16th week) to 26.3 µg/ml (38-
42
nd
 week). SP-A is highly regulated near term; it shows a clear rise from 3 µg/ml (30-31st 
week) to 24 µg/ml (40-41st week) when compared to SP-D (Miyamura et al., 1994). At term 
(39
th
 week), the levels of SP-A and SP-D reach their maximum 4978 µg/ml and 793 µg/ml, 
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respectively (Miyamura et al., 1994). Thus, changes in the AF levels of SP-A and SP-D can 
act as a biomarker to assess fetal maturity (Table 3). At term, there is at least 2-fold increase 
in the levels of SP-A in the umbilical cord blood in newborn babies delivered by spontaneous 
labor between 36 and 38 weeks (4.8-50.2 ng/ml) when compared to those delivered through 
cesarean section i.e., with no labor (2.7-21.7 ng/ml) (Cho et al., 1999).  
A similar pattern of increase in the AF level for MBL is observed with advancing 
gestational age (Malhotra et al., 1994); however, it varies significantly before and after 35 
weeks of gestation (304 µg/ml and 1070 µg/ml, respectively) compared to the serum level of 
MBL (995 µg/ml) (Malhotra et al., 1994) (Table 3). The C1q level in AF is less than 0.5 
µg/ml compared to its level in the plasma (80 µg/ml) (Miyamura et al., 1994). The level of 
fetal MBL in the umbilical cord blood (venous and artery 0.70 µg/ml) is low when compared 
with the maternal peripheral blood before elective cesarean section (1.11 mg/ml) (Kielgast et 
al., 2003; Oudshoorn et al., 2008). The gestational age-dependent changes in the AF levels of 
collectins may have distinct roles at different stages of pregnancy and parturition in addition 
to a protective role against infection and inflammation. 
 
Pregnant uterus (amnion, chorion, decidua, myometrium and placenta) 
SP-A and SP-D are present in the human fetal membranes, amniotic epithelium and chorionic 
membrane (Han et al., 2007), the chorio-decidual layer of the late pregnant uterus (Miyamura 
et al., 1994), trophoblast of late normal placental villi, early human placenta (Sati et al., 
2010), cytotrophoblast, intermediate trophoblast, and syncytiotrophoblast of early gestation 
(Miyamura et al., 1994; Leth-Larsen et al., 2004) (Table 2; Figure 3).  Cytotrophoblasts and 
mesenchymal cells have been shown to express MBL during early pregnancy (Kilpatrick et 
al., 1995; Yadav et al., 2016). MBL is synthesized by human term placenta and decidua 
(Yadav et al, 2014). Complement-activating natural IgG is found deposited on the placental 
tissues (Richani et al., 2005; Bulla et al., 2008). Both early (C1q and C4) and late (C5, C6, 
C9) complement components are seen in the placenta. C1q is widely distributed around the 
fetal vessels, spiral arteries, trophoblast, decidual endothelial cells, and extravillous 
trophoblasts (EVT) (Figure 2 and 3) (Bulla et al., 2008, 2009; Agostinis et al., 2010). We 
recently showed the expression of SP-A, SP-D and C1q in early human decidua specifically 
on stromal cells and EVT by immunohistochemistry. Transcripts of A, B and C chains of C1q 
were also detected in early human decidual stromal cells (Madhukaran et al., 2015a). SP-A 
and SP-D are synthesized by human term and first trimester placental and decidual tissues 
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(Yadav et al, 2014; Yadav et al, 2016). As the expression of collectins in gestational tissues is 
established, an underlying role that directs cellular processes and other signaling pathways in 
pregnancy needs to be examined.  
 
Role of collectins and C1q in early pregnancy  
Recently, the expression and localization of SP-A, SP-D and C1q was examined in human 
decidua within the decidual trophoblast and stromal cells (DSCs) (Bulla et al., 2009; 
Madhukaran et al., 2015a). There is evidence to suggest that transcription factor PU.1 
regulates the decidual expression of C1q in early pregnancy (Madhukaran et al., 2015b). This 
suggests that C1q, regulated by PU.1, may be a critical factor in trophoblast and stromal cell 
development (differentiation and proliferation) at the feto-maternal interface.  
Our preliminary analysis using triple immunofluorescent staining identified 
trophoblast (verified by intracellular marker cytokeratin 7, CK-7) exhibiting the expression of 
PU.1 and C1q within the first trimester decidual cells (Figure 4). A considerable percentage 
of the decidual cells stained for trophoblasts and cytoplasm of trophoblasts were positive for 
C1q. In addition, PU.1 positive cells accounted for 70-80% of trophoblasts expressing C1q, 
pointing to considerable variation in the localization of PU.1 in the nucleus and cytoplasm of 
the trophoblasts. These data suggest that cytoplasmic localization of PU.1 widespread in the 
cells of trophoblast lineage might be essential for regulating the cross-talk between 
trophoblast and C1q function throughout gestation and for mediating immunotolerance and 
implantation. Understanding the role of PU.1 expression on trophoblast lineage development 
can have a significant impact on the immunotherapy for adverse pregnancy such as abortion, 
miscarriage, and preeclampsia (PE) (Madhukaran et al, unpublished). Our study validates a 
previous report showing that C1q localizes to the EVT and promotes its invasion, spiral 
artery remodeling and normal placentation at the feto-maternal interface (Singh et al., 2011). 
Further, the evidence that C1q produced by decidual endothelial cells (DECs) suggests that it 
acts as a link between the endovascular trophoblasts and spiral artery endothelial cells, 
involving the MAP kinase pathway via gC1qR, a receptor for the globular head region of 
C1q (Bulla et al., 2008; Agostinis et al., 2010;  Agostinis et al., 2012).  
SP-D levels in the uteri progressively decrease from 0.5 days post coitus (dpc) to 2.5 
dpc during early pregnancy, suggesting relevance of uterine SP-D in peri-implantation period 
in mice (Kay et al, 2015). SP-D gene deficient mice showed significantly increased pre-
implantation loss, leading to a considerably reduced litter size (Kay et al, 2016, unpublished). 
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During spontaneous abortion, SP-A was significantly downregulated while SP-D was 
upregulated at the feto-maternal interface (Yadav et al, 2016). 
There is a paucity of information regarding the role of SP-A and SP-D in early human 
pregnancy. A prospective (pilot) study was carried out in decidua obtained from 17 pregnant 





 week of gestation and 5 with a history of miscarriages (2 samples from early 
pregnancy and 3 from after labor). Expression of SP-A1, SP-A2, SP-D, C1q A, C1q B, and 
C1qC was measured in both groups at week 7, 8, 9, 10, 39 and after labor. The levels of SP-
A1 and C1qB during early gestation (Week 7-10) were significantly higher in women with 
normal pregnancy (Figure 5 A) and recurrent pregnancy loss (RPL) case (39+1) with a 
history of 2 miscarriages (Figure 5B). The number of human decidua needs to be increased to 
prove the statistically significant differences in expression of SP-A1, SP-A2, SP-D, C1qA, 
C1qB and C1qC genes in human decidua (Madhukaran et al, unpublished). Thus, evaluating 
the gene expression of collectins and C1q can be clinically significant for predicting the 
outcome of pregnancy. Our studies provide considerable evidence that the human SP-A1 and 
C1qB are associated with normal and complicated pregnancy, but their functional 
significance is not yet known. It is likely that SP-A1 might play a role in influencing 
immunosuppressive properties on T-lymphocytes. It has been earlier shown that an 
interaction between SP-A1 and TGF-β triggers   immunosuppressive effect on IL-2 secreted 
by T lymphocytes (Kunzmann et al., 2006). 
MBL was first observed in the endothelial cells and Hofbauer cells (placental 
macrophages) in the first trimester placenta. Within the decidua, endovascular trophoblasts 
and endothelial spiral arteries express MBL (Kilpatrick et al., 1995). The increased MBL 
level in the maternal blood and serum during early normal pregnancy (first trimester) appears 
to suggest an involvement of MBL in normal placentation and establishment of pregnancy 
(van de Geijn et al., 2007a).  
The ability of SP-A, SP-D, MBL and C1q to act as opsonins confirms enhanced 
opsonization and phagocytosis of recognized pathogens thus contributing to the innate 
immune response (Nauta et al., 2004; Kishore et al., 2006). All these properties makes it 
possible to suggest that the expression of collectins and C1q in early gestational tissues may 
have a wide range of protective functions, including eliminating pathogens, apoptotic 
materials, and simultaneously, modulating the immune response during early pregnancy, all 
of which require further investigation. While the significance of collectins in parturition has 
been of intense focus over the past decade, the importance of collectins in implantation, 
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immune tolerance, regulation of normal placental development and function, regulation of 
trophoblast invasion, differentiation, proliferation and migration remain to be investigated. In 
addition, there have been no reports on gestational tissue-specific functions of SP-A, SP-D, 
MBL and C1q in early pregnancy.  
 
Collectins and C1q in parturition and complicated pregnancy 
Parturition is an inflammatory process and is associated with significant upregulation of SP-
A, SP-D and MBL levels in AF, with advancing gestational age (Miyamura et al., 1994). Any 
mutations, SNPs, unusual expression or deficiency involving SP-A, SP-D, MBL, or C1q can 
be associated with pregnancy complications. Multiple etiologies for various pregnancy 
complications have been described; however, over one-half of the cases remain unexplained. 
Although the physiology of pregnancy, initiation and regulation of parturition in human and 
mice are quite distinct (Bezold et al., 2013), studies using murine models, deficient or over- 
expressing genes, have been used to understand the role of SP-A, SP-D, MBL or C1q in 
pregnancy.  
 
SP-A and SP-D 
SP-A, SP-D and MBL level reaches maximum at term in AF, which suggests its association 
with pregnancy maintenance and parturition. Parturition is marked by local production of 
numerous factors including pro-inflammatory cytokines and hormones (glucocorticoids and 
PGF2α) (Myatt and Sun, 2010). Expression of SP-A in mouse fetal lungs (after 17 dpc) and 
its secretion in AF provide a signal for initiation of parturition (Condon et al., 2004; 
Mendelson and Condon, 2005). Gestational increase in the AF SP-A level augments the 
production of IL-1β, NF-κB and PGF2α and infiltration of AF macrophages into fetal 
membrane, myometrium, uterus and cervix, which probably serve as a signal for labor 
(Condon et al., 2004). In pregnant mice, intra-amniotic injection of purified SP-A at 15.5 dpc 
stimulates IL-1β production, leading to preterm delivery within 6-24 hr (Figure 6). 
Conversely, injecting anti-SP-A antibodies into the mice amniotic sac can delay parturition 
by up to 24 hours (Condon et al., 2004). The view by Condon et al. that fetal SP-A triggers 
the onset of labor is consistent with our recent finding that SP-A and SP-D levels are low 
during pre- (17.5dpc) and near (19.5 dpc) parturition in the murine decidua (Madhukaran et 
al., 2015c). Despite the elevated SP-A and SP-D levels in the AF at term, the transcript level 
of decidual (maternal) SP-A was absent. The withdrawal of decidual SP-A might be 
responsible for controlling the functional activation of fetal-derived SP-A which regulates 
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parturition at term by two different pathways: the endocrine pathway where SP-A in the fetal 
circulation reaches the placenta and the uterus directly, or with the support of maternal SP-A 
produced before term. In the paracrine pathway, the fetal lung-derived SP-A enters the AF to 
exert its effect by increasing AF concentration (26
th
 week to 32
nd
 week) on the fetal 
membrane (amnion and chorion) to transmit the signal to the myometrium and cervix for the 
initiation of labor. A better understanding of the role of the fetal SP-A in signalling 
parturition is required to define the association of fetal and maternal SP-A in parturition. This 
will also enable us to recognize and prevent the inflammatory responses stimulated in various 
pregnancy complications  
In contrast, SP-D levels were found to decrease with the gestation age from 17.5 dpc 
to 19.5 dpc in murine decidua (Madhukaran et al., 2015c). We suspect that increased SP-D 
level at 17.5 dpc could reflect paracrine effect on fetal membrane, cervix and myometrium 
involved in hindering prostaglandin E2 activation required for labor. The subsequent 
decrease in SP-D at 19.5 dpc might be functional withdrawal of SP-D prerequisite for 
upregulation of PGE2, cyclo-oxygenase enzyme-2 (COX2) and increased myometrial 
sensitivity to estrogen in association with labor process. Altogether, SP-A and SP-D in 
decidua indirectly regulate parturition. We also demonstrated the host defense role for SP-A 
and SP-D in the decidua at term, which has the ability to inhibit the release of TNF-α upon 
LPS challenge, as an indicator of intrauterine infection preventing preterm labor and birth 
(Madhukaran et al., 2015c). 
Before labor, decidual SP-A is highly expressed when compared to the levels in those 
with labor. Surprisingly, SP-A-induced (100 µg/ml) pro-inflammatory soluble factors (IL-6, 
IL-8, TNF-α, IL-1β, MCP-1, MMP-3 and VEGF) did not exhibit any significant difference in 
stromal cells (Snegovskikh et al., 2011). Additionally, detailed investigation of prostaglandin 
(PGF2α) production revealed that the presence of SP-A in the endometrium selectively 
inhibits PGF2α production, suggesting that endometrial SP-A expression may specifically 
regulate prostaglandins during labor (Snegovskikh et al., 2011). In human myometrial cells, 
SP-A from the fetal membrane induces actin stress fibre formation by controlling F-actin 
filament organization, suggesting that SP-A regulates the initiation and maintenance of 
uterine contraction (of smooth muscle cells) for labor (Garcia-Verdugo et al., 2008; Breuiller-
Fouché et al., 2010; Sotiriadis et al., 2015).  
Despite strong indications that SP-A is an important signal linked with parturition, 
little is known about the underlying molecular events. Moreover, fetal macrophages were not 
found in the maternal tissue (myometrium) at term (Kim et al., 2006) and SP-A gene-
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deficient mice were able to go into spontaneous labor (Korfhagen et al., 1998; Montalbano et 
al., 2013). Subsequent studies proved SP-A to be anti-inflammatory (Figure 6). In vitro 
interaction of AF SP-A with human placental amnion has been proposed to down-regulate the 
expression of IL-1β, CXCL2 and CXCL5, a mechanism essential for initiation of parturition 
(Lee et al., 2010). Injection of SP-A into the extra-amniotic space within the uterus exposed 
the anti-inflammatory role of fetal lung SP-A with downregulated expression of 
inflammatory molecules (IL-1β, TNF-α, NF-κB and CCL5) via TLR2 in the placenta and 
fetal tissues. Simultaneously, SP-A was shown to enhance the expression of anti-
inflammatory molecules (CXCL1 and IL-10) within the placental, fetal and uterine tissues 
that can prolong the gestation (Agrawal et al., 2013). A recent study has examined 
inflammatory and contractile genes from mice deficient in SP-A or SP-D. Prolonged 




 litter) with reduced 
levels of IL-1α, IL-1β and IL-6 in the myometrium compared to the wild-type mice.  
Furthermore, the expression of contractile genes (oxytocin receptor and connexin-43) was not 
significantly higher than control delaying parturition (Montalbano et al., 2013). Induction of 
oxytocin receptor (OXTR) and connexin 43 (CX43) expression and secretion of GROα 
(chemokine CXCL1) and IL-8 by the myometrial cell line, ULTR, following treatment with 
SP-A and SP-D provides further evidence that the two collectins play a key role in 
modulating events prior to labour by reconditioning the human myometrium and thus shifting 
the uterus from a quiescent to a contractile state (Sotiriadis et al., 2015).  
The association of transcription factor, Forkhead box M1 (FOXM1), with lung 
maturity and expression of SP-A has been examined in an animal study. FOXM1 was utilized 
for studying the fetal lung development due to its regulatory functions related to cellular 
proliferation, differentiation, vascular remodelling and metabolism. The study found that as 
FOXM1 (mRNA and protein) expression increased, SP-A (mRNA) expression decreased in 
rabbit fetal lungs (Hahn et al., 2013). A significant delay in parturition of nearly 38 hrs has 
been recently reported in steroid receptor coactivators 1 and 2 (SRC-1 and SRC-2) double-
deficient mice with reduced expression of NF-κB, PGF2α, and contractile genes (oxytocin 
receptor, connexion-43, cyclooxygenase 2, prostaglandin-endoperoxide synthase 2), SP-A, 
lysophosphatidylcholine acyltransfereae-1 (LPCAT-1), pro-inflammatory 
glycerophospholipid and platelet-activating factor (PAF) in near term fetal lungs, maternal 
myometrium and in fetal AF (Gao et al., 2015). Exogenous injection of SP-A (3 µg/sac) or 
PAF (0.25 ng/sac) into the amnion of SRC-1/2- deficient mice at 17.5 dpc activated the 
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downstream signals in parturition cascade by enhancing NF-κB and contractile genes. SP-A 
or PAF injection lowered both steroidogenic acute regulatory protein (StAR) and P4 in 
circulation (Gao et al., 2015). This correlation between SRC-1/2 and SP-A or PAF expression 
highlights fetus signal in parturition. Therefore, maturation of fetal lungs and SP-A secreted 
from lungs may be used as a potential marker for forecasting lung maturity and survival of 
the fetus by generating a signal to initiate labour at term. The importance of SP-D in 
parturition has also been shown by the finding that methionine allele SP-D gene 
polymorphism (methionine allele, Met31Thr) in the fetus is associated with spontaneous 
preterm birth within the Northern Finland population (Karjalainen et al., 2012).  
Since SP-A serves as a key signal molecule for initiation of parturition, levels of AF 
SP-A at term in labor (spontaneous human parturition) and without labor have been 
measured. AF SP-A level was shown to decrease (1.2-10.1 µg/ml) in spontaneous labor at 
term when compared to women not in labor (2.2-15.2 µg/ml) (Chaiworapongsa et al., 2008b). 
However, an insignificant difference in the levels of SP-A was observed in maternal serum 
before and after labor (Cho et al., 1999). The biological significance of placental SP-A, SP-D 
and MBL in parturition is further supported by the altered levels of SP-A, SP-D and MBL in 
spontaneous term labor (Yadav et al., 2014).  Another study using SP-A or SP-D over-
expressing mice has shown that maternal challenge with an increasing concentration of LPS 
(intraperitoneal injection of smooth LPS) from 17 dpc till term (12 µg, 15µg, 20µg and 25 
µg/mouse) modulates the LPS-induced cytokine response within the mother and the fetus 
inducing spontaneous preterm labor (Figure 6). Increased expression of TNF-α and IL-10 in 
AF and fetal membrane was detected when compared to the wild type controls (Salminen et 
al., 2008, 2011, 2012). Thus, higher SP-A or SP-D concentrations do not correlate with the 
timing of labor, but instead, they increase the risk of preterm birth and fetal mortality. It is 
likely that an increase in maternal SP-A or SP-D levels during infection induced preterm 
labor can be a useful marker to predict the outcome of pregnancy, though it would require 
extensively planned, large clinical studies.  
 
MBL  
Very little is known about the role of MBL in parturition. Due to the increase in the level of 
MBL in first trimester till term with sharp decrease after delivery, MBL is believed to be 
involved in the parturition process and onset of labor.  MBL-2 gene polymorphism has been 
reported to affect the immunological events in normal pregnancy. The presence of MBL-2 
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gene polymorphism is beneficial at times but not in all cases, as it is also associated with 
complicated pregnancies. In immunocompromised women with genetic polymorphisms and 
low levels or deficiency of MBL during mid-pregnancy are related to functional changes in 
the placenta; in particular, placental lesions, placental insufficiency, and inflammatory 
infiltrates are associated with low gestational age and low birth weight (van de Geijn et al., 
2008), recurrent abortions, idiopathic recurrent late pregnancy loss (Christiansen et al., 2009), 
unexplained recurrent miscarriages (Christiansen et al., 2002; 1999; 2009; Kruse et al., 2002), 
chorioamnionitis, and PE (van de Geijn et al., 2007b; Holmberg et al., 2008). There is also an 
increased expression of MBL in uterine lumen during oocyte collection in patients with 
unexplained infertility when compared to tube infertility patients (Oger et al., 2009).  
Bodamer et al. have examined polymorphisms in the coding and promoter regions of 
MBL-2 in premature infants. In particular, codon 52 was demonstrated to have a significant 
association with the group of infants born preterm (before 36 weeks) compared with the 
infants born at term (Bodamer et al., 2006). In a correlation study between MBL levels and 
recurrent miscarriage, a low level of serum MBL (0.1 mg/ml) was observed in blood samples 
obtained from both male and female partners with recurrent miscarriage (Kilpatrick et al., 
1996, 1999). Furthermore, decreased MBL levels at the feto-maternal interface have been 
reported to be insufficient to regulate infection-induced inflammatory response leading to 
fetal loss (Kilpatrick et al., 1995). Taken together, maternal gene polymorphisms (Codon 52 
and Codon 54) with low MBL serum levels pose greater risk to the fetus by increasing 
susceptibility to infection. The pro-inflammatory reactions induce preterm labor and birth (< 
29 weeks) with reduced weight owing to reduced fetal growth and development. Further 
studies are thus required to identify the role of fetal variant MBL genotype in causing 
premature delivery and preterm birth. In contrast, others reported that MBL-2 genotypes on 
promoters MBL variants (-550 C > G and -221 G>C) and structural MBL variants with 
missense mutation (R52C, G54D, G57E) in exon 1 with low levels of MBL did not 
contribute or influence unexplained recurrent pregnancy loss or miscarriage (Baxter et al., 
2001; Berger et al., 2013). 
In the gene encoding MBL, six SNPs are identified at position -550 H/L (G/C) and -
221 X/Y (C/G) in the promoter region, +4 P/Q (C/T) in the translated region. Three 
polymorphisms located in exon 1 at codon 52 A/D (Arg→Cys), codon 54 A/B (Gly → Asp) 
and codon 57 A/C (Gly → Glu). The SNPs in promoter region at position -550 and -221 form 
four haplotypes HY, LY, LX, HX  out of which 7 coding variants are observed –HYPA, 
LXPA, LYQA, LYPA, HYPD, LYPB and LYOC (Madsen et al., 1995, 1998). High MBL 
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levels in serum have been demonstrated to have pro-inflammatory properties against the fetus 
resulting in preterm labor. Maternal serum from women undergoing normal deliveries had 
high fetal MBL genotype levels (H/L)YA/(H/L)YA and (H/L)YA)/LXA associated with a 
significantly shorter gestational age (before 29 weeks of gestation) when compared with 
intermediate (LXA/LXA and (H/L)YA/O) and low  (LXA/O and O/O) MBL serum genotype 
group. Approximately 13% of the fetuses delivered were of high MBL serum genotype levels 
while 3% were intermediate and low MBL serum genotype groups (van de Geijn et al., 
2008).  
In normal pregnancy, EVT invades the decidua until it reaches the inner third of the 
myometrium and the extent of trophoblast invasion therefore needs to be regulated. 
Inadequate tapering of maternal arteries and improper trophoblast invasion is associated with 
PE (Rodeck and Whittle, 2009). PE is a common pregnancy disorder characterized by 
abnormal placental function, hypertension, and proteinuria. Several studies have attempted to 
associate MBL levels and MBL genotypes with PE; most of them showed functional 
association of MBL levels with PE pathogenesis. In a comparative study, plasma from 
pregnant women with and without PE were examined by proteomic analysis.  Wang et al. did 
not find any significant association between MBL levels in plasma and PE compared with 
normal pregnancies (Wang et al., 2007). Similarly, a high frequency of maternal MBL 
genotype (3 structural and 2 promoter polymorphisms) did not show any association with PE 
(van de Geijn et al., 2007b).  
The gene polymorphisms of MBL-2 gene in the structural region as well as promoter 
region that contribute to low levels of MBL showed a significant association with the 
pathogenesis of PE in Brazilian women (Vianna et al., 2010). Maternal MBL-2 genotype 
(variant B allele, codon 54) is implicated in a protective role against the development of PE 
and PE-associated intrauterine growth restriction (IUGR) via complement activation (Figure 
7). The frequency of MBL-2 gene polymorphism compared between women with PE and full 
term controls were examined. Importantly, higher MBL-2 genotype levels were detected in 
PE women (~86-95%) compared to full-term controls (~70-83%) (Sziller et al., 2007a). 
Excessive lectin pathway activation and an increase in placental MBL levels are likely to 
impair trophoblast invasion and spiral arteries formation, resulting in activation of hypoxic 
signaling pathway related to PE (Girardi et al., 2006). With an increase in maternal MBL-2 
genotype activity, their ability to activate complement is affected, as low serum MBL levels 
are unable to interact with MASPs, thus protecting the placenta against development of PE. 
Maternal variant A (wild type allele) in codon 54 of MBL2 has been proposed to increase 
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MBL levels in serum that is associated with the development of PE (Figure 7). Recently, 
Agostinis and colleagues implicated MBL as a major protein found to be increased in the sera 
obtained from PE patients, which is potentially responsible for inhibiting the cell 
communication between fetal trophoblasts and decidual endothelial cells preventing 
trophoblast invasion (Agostinis et al., 2010). This is consistent with the findings in earlier 
studies in which C1q expressed by decidual cells (endothelial cells and trophoblasts) was 
shown to enhance the cross-talk between fetal trophoblasts and decidual endothelial cells 
essential for trophoblast migration and invasion, spiral artery formation, vascular remodeling 
and placental development (Bulla et al., 2008; Agostinis et al., 2010). The best evidence for 
protective role of MBL has come from studies of abortion-prone mouse model (CBA/J X 
DBA/2) of PE. MBL-A has been detected at the early stages of pregnancy (3.5dpc) while 
MBL-A deficiency demonstrated to prevent pregnancy loss. Furthermore, DBA/2-mated 
CBA/J mice were able to prevent fetal loss efficiently after polyman2 (mannosylated 
molecule that binds to MBL-A with high affinity) treatment (Petitbarat et al, 2015). Thus, 
increased levels of MBL in PE may contribute to the failure of the endovascular invasion of 
trophoblast cells.  
In another study, however, no systematic functional activity of MBL-MASP2 levels 
were found to correlate with the disease onset, severity, fetal growth restriction, or birth 
weight linked to PE (Csuka et al., 2010). The study classified PE and normal pregnant 
participants into three groups, namely MBL deficient, MBL normal and MBL high. 
Importantly, complement activation was relatively higher in both MBL high as well as MBL 
deficient categories. It is speculated that altered (both low and high) levels of MBL can give 
rise to dysregulated complement activation, thus contributing to PE (Csuka et al., 2010). This 
may explain why some of the studies did not find a significant association of PE with MBL 
levels. It is likely that deficiency or low levels of MBL in pregnancy probably lead to 
accumulation of apoptotic cell debris, excessive inflammatory responses, and an enhanced 
production of autoantibodies, resulting in adverse pregnancy outcomes.  In the case of IUGR 
neonates at birth, the concentration of MBL level in the cord blood remains significantly low, 
confirming that altered levels of MBL contribute to adverse pregnancies (Briana et al., 2012). 
Given that IUGR neonates are more susceptible to infections, MBL’s role in host defense in 
these neonates is easy to understand. Therefore, altered serum MBL levels can be useful as a 





C1q deficiency is associated with improper placental formation, trophoblast invasion, 
impaired angiogenic balance and an increased risk of fetal death resulting in miscarriages, 
preterm delivery, and PE (Agostinis et al., 2010; Singh et al., 2011). Lower concentration of 
anti-C1q antibodies and higher levels of IL-15 have been observed in ectopic pregnancies and 
missed abortions when compared to complicated pregnancies (Daponte et al., 2013). Storelli 
et al. have reported that mothers exposed to polychlorinated biphenyls (PCBs) are at a higher 
risk of spontaneous miscarriage, stillbirth and fetal resorption (Storelli et al., 2011). Decidual 
levels of gC1qR correlate with enhanced PCBs content in plasma in mothers who underwent 
spontaneous abortion (Gu et al., 2012). Reduced percentage of apoptotic cells were observed 
in human trophoblast cell line treated with PCBs compared with cells treated with PCBs and 
gC1qR small interfering RNA (Gu et al., 2012). This upregulation of gC1qR may have 
evolved as a defense mechanism to reduce damage to the human trophoblast cells exposed to 
PCBs resulting in complicated pregnancies.  
Villitis of unknown etiology (VUE) is a complication of pregnancy characterized by 
inflammation in the chorionic villi. It can be caused by either maternal infection or when 
placental tissues are affected by immune system i.e. NK cell attack via cytotoxic T cells 
(Tamblyn et al., 2013). Distribution of C1q has been observed in the placenta with VUE and 
within the stroma of inflamed villi suggesting an important contribution of C1q in Villitis 
(Altemani et al., 1992). 
Human placentae (20 normal and 20 PE) were studied by immunofluorescence for the 
presence of complement components; C1q was increased in PE as compared to normal 
tissues (Sinha et al, 1984). C1q knock-out
 
mice are known to show a defect in the clearance 
of apoptotic cells and developed glomerulonephritis (Botto et al, 1998). This study hinted that 
C1q deficiency might be responsible for accumulation of apoptotic trophoblasts in the 
pathogenesis of PE. An association of the absence or low levels of C1q in PE patients was 
recently shown (Agostinis et al., 2010). Subsequent studies confirmed that C1q deficient 
mice develop symptoms similar to PE; these features include hypertension, albuminuria, 
endotheliosis, decreased placental VEGF, increased soluble VEGF receptor 1 (sFlt-1), 
increased oxidative stress, decreased blood flow, increased fetal death, diminished litter size, 
abnormal invasion of trophoblasts, and increased levels of STAT-8 (inhibitor of trophoblast 
migration) (Singh et al., 2011). However, in one of the studies, C1q mRNA expression at 
placenta was not different between PE women and normal controls (Burma et al, 2012). 
Syncytiotrophoblast microvesicles (STBM) are pro-inflammatory and circulate in increased 
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amounts in PE women and C1q was observed to be one of the 538 proteins unique to PE 
STBM (Tanetta et al, 2012). Interestingly, a recent study was able to relate C1q deposits that 
occur in early onset of PE placenta, with immune tolerance and clearance of apoptotic cells. 
The authors have observed more C1q deposition in endothelial stroma, large villi and 
fibrinoid necrotic areas in the placenta of early onset than in late onset PE women. 
Additionally, C1q deposit areas had C4bp protein binding to apoptotic fragments and 
trophoblastic syncytium knots (Lokki et al., 2014). These data suggest that C1q, with C4bp 
factor released from placenta, may be responsible for immune tolerance by promoting 
clearance and phagocytic uptake of apoptotic trophoblast cells accumulated in the PE 
placenta. Association of both low and high C1q levels with PE suggests that any 
dysregulation in C1q levels may lead to anomalous placental development. .  
It is evident now that SP-A, SP-D, MBL and C1q have a regulatory role in pregnancy 
maintenance and parturition. However, there is yet a lack of clarity on the underlying 
mechanisms and roles of these proteins in different phases of pregnancy. Once we have this 
understanding, it may help devise strategies to ameliorate or prevent adverse pregnancy 
outcomes. Overall, the studies suggest that the regulation of inflammation at the feto-
maternal interface is critical, and these molecules, under hormonal influence, are integral to 
regulation of inflammation. SP-A has the ability to elicit inhibitory or stimulatory response 
favouring pregnancy maintenance and stimulating parturition driven by maternal or fetal 
demand, depending on the gestational tissues, receptors and tissue-specific cells. It is difficult 
to generalize the role of SP-A as an initiator of parturition/contraction due to inconsistency 
and significant gaps reported so far. However, observational inconsistencies could be due to 
different endocrine control of parturition in mouse and humans; besides, SP-A could be 
multifunctional. The underlying mechanism by which fetal or maternal SP-A triggers 
parturition, evidence for migration of fetal lung specific macrophages into the maternal 
compartment at term, how these regulatory proteins maintain pregnancy till term although 
their levels are lower in AF, functional significance of their increase with advancing 
gestation, hormonal stimulation of fetal lung SP-A triggering myometrial contraction and 
uterine ripening (SP-A dependent pathway) needs to be examined during pregnancy. Most 
studies have focussed on parturition and further studies on SP-A, SP-D, MBL and C1q in 





C1q and collectins in pregnancy associated infections 
During pregnancy, microbial infections of the genital tract by Escherichia coli, Klebsiella 
pneumonia, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis, and 
intrauterine infection such as chronic hepatitis B virus (HBV), and cytomegalovirus (CMV) 
cause fetal damage leading to miscarriage, infertility, ectopic pregnancies, preterm labor via 
pro-inflammatory immune response.  
 
SP-A and SP-D  
During intra-amniotic infection (IAI), bacterial LPS lining the outer membrane of Gram-
negative bacteria trigger potent pro-inflammatory immune response resulting in 
chorioamnionitis, preterm labor, and delivery. Hence, the AF gets exposed to several 
inflammatory molecules, cytokines and soluble factors. The progressive increase of SP-A and 
SP-D in the AF during pregnancy is likely to have protective role against intrauterine 
infections by controlling the inflammatory response. Inflammation of the fetal membrane due 





 week of gestation during which the concentration of SP-A and SP-D are reduced (Lahra 
and Jeffery, 2004). However, Han et al. found no significant difference in SP-A mRNA 
expression in the chorioamniotic membrane from women with chorioamnionitis preterm 
delivery and from those without chorioamnionitis preterm delivery. However, the level of 
SP-A was increased at term in women with chorioamnionitis compared to spontaneous labor 
at term (Han et al., 2007). The comparative analysis of AF SP-A and SP-D levels examined 
in women with and without IAI showed no significant differences between the SP-A/SP-D 
and IAI infection in the AF (Chaiworapongsa et al., 2008b). Conversely, an excessive 
increase in SP-A due to maternal infection (bacterial) at term pregnancy has been shown to 
have a negative effect on pregnancy triggering labor. In animal models, intra-peritoneal 
administration of LPS on 16-17
th
 day of gestation induces SP-A, but not SP-D, secretion in 
the uterus at term pregnancy, and initiates parturition (Salminen et al., 2011, 2012). 
Chlamydia trachomatis infection in the female reproductive tract leads to fallopian tube 
damage and infertility (Paavonen and Eggert-Kruse, 1999). It has been shown that SP-D, but 
not SP-A, can inhibit Chlamydia trachomatis infection in a dose dependent manner in the 
endocervical epithelial cell line (Oberley et al., 2004, 2007). Additionally, SP-A is also 
attributed to neonatal immunity. Initially, SP-A knock-out mice were found to be more 
susceptible to LPS induced inflammatory response with high rate of fetal mortality compared 
to wild type mice. This inflammatory response was reconciled with oral administration of SP-
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A which increased the survival of the fetus (George et al., 2008). In addition, exogenous 
administration of SP-A or SP-D has also been shown to inhibit LPS mediated TNF-α via 
decidual macrophages at 17.5 dpc. Thus, decidual SP-A and SP-D appear to offer protection 
against intrauterine infection towards the term (Madhukaran et al., 2015c). The molecular 
mechanism by which the inflammatory condition is modulated is not understood fully. 
 
MBL   
Bacterial vaginosis and vulvovaginal candidiasis infection are the most common threat during 
pregnancy. During early stages of menstrual cycle, there is a significant change in the vaginal 
microbial flora within the cervico-vaginal cavity (Romero et al., 2014). MBL, produced by 
the vaginal cells, are detected in the vaginal lavage along with other normal microflora (Bulla 
et al., 2010). The polymorphism in MBL2 gene (condon 54) on exon 1 leads to unstable 
polymeric MBL proteins that are rapidly degraded (Babovic-Vuksanovic et al., 1999). 
Carriers of this allele have reduced levels of MBL in their circulation and in their vaginal 
fluid, making them more susceptible to recurrent vulvovaginal candida infection (Babula et 
al., 2003). Women with Chlamydia trachomatis infection with variant allele A or B at codon 
54 in MBL-2 gene are at a greater risk for fallopian tube occlusion than wild type allele A 
(Sziller et al., 2007b). Low levels of MBL are common in patients with tubal factor 
infertility, sepsis, and septic shock. However, there seems to be no association between MBL 
deficient genotype and tubal factor infertility (Laisk et al., 2010, 2011; Wahab Mohamed and 
Saeed, 2012). Low serum MBL levels can be used as markers for septic shock in mothers and 
to evaluate the clinical outcome in neonates. MBL-2 gene polymorphism (codon 54, allele B) 
in the lower genital tract could serve as a marker for predicting Chlamydia trachomatis 
infection associated with higher risk of fallopian tube damage and early pregnancy loss. 
Viral infections such as HBV and CMV, and N. gonorrheae get transmitted from 
mother to the fetus. These pathogens infect the reproductive tissues such as placenta and 
chorioamniotic membrane. MBL, an acute phase reactant, is found to be increased in serum 
after viral infection (Hakozaki et al., 2002). In human pregnancy, maternal HBV promotes 
increase in fetal MBL, which probably reflects the protective role of MBL in inhibiting 
intrauterine infection transmission of HBV from the mother to fetus (Wu et al., 2013). Low 
serum levels of MBL with gene polymorphisms at codon 52 (exon I) and codon 54 (allele B) 
have been associated with disease progression and poor prognosis of HBV (Thio et al., 2005). 
In contrast, a high serum level of MBL is linked to patient survival with HBV infection 
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(Hakozaki et al., 2002). Although MBL and HBV have been extensively investigated in 
human pregnancy, the association of MBL polymorphism with prognosis of HBV infection 
remains controversial.  A study by Hohler et al. was unable to establish a connection between 
MBL polymorphisms and susceptibility to HBV infection (Hohler et al., 1998). Similarly, a 
recent study on SNPs (rs2120131, rs4935047, and rs7095891) in the MBL-2 gene in the 
Chinese Han population found no association with the susceptibility to HBV (Zhang et al., 
2013). Prenatal and perinatal neonates from CMV infected mother with MBL-2 gene 
polymorphism when compared with non-infected mothers did not show any increase in the 
susceptibility of CMV infection (Szala et al., 2011). The conflicting results may be due to 
patient recruitment (age, race, origin and previous history), different methodology, control 
samples, comparison studies, limiting within specific population, sample collected during 
different periods of pregnancy, and sample size. Further studies are needed to clarify the 
potential impact of MBL-2 polymorphism in intrauterine infection.  
There is ample evidence to suggest that Plasmodium falciparum infection plays an 
important role in pregnancy outcomes. For instances, P. falciparum-infected erythrocytes 
membrane protein-1 (PfEMP1) that has affinity for chondroitin sulfate A were observed to 
infect the red blood cells by residing in the endothelium lining the intervillous space within 
the placenta. Additionally, they up-regulate infiltration of inflammatory cells and cytokines 
response via antigen presenting cells leading to massive chronic intervillositis (MCI), IUGR 
and premature labor (Fried and Duffy, 1996). Although MBL has been reported to recognize 
and interact with P. falciparum-infected erythrocytes (Garred et al., 2003), MBL-2 
polymorphism at codon 57 in exon 1 showed no association with placental malaria infection 
with the concentration of MBL or MBL-2 genotypes measured in the intervillous space 
(Thevenon et al., 2009). MBL could opsonize P. falciparum to eliminate the infection 
through excessive complement activation (Silver et al., 2010) in placental malaria but 
simultaneously damage the normal placental function (tissue integrity, endothelial activation, 
vascular remodelling) (Silver et al., 2010). This excess complement activation may alter the 
pathogenesis of placental malaria leading to tissue hypoxia, enhanced vascular permeability, 
and improper placental vasculature contributing to adverse pregnancy outcomes. 
Furthermore, binding of MASP-2 with R439H mutation to MBL also reduces the enzymatic 
activity due to excessive complement activation (Thiel et al., 2009). This aberrant mutation 
observed in MASP-2 influences alteration in MBL-2:MASP-2 complex and complement 
activation (Holmberg et al., 2008, 2012). Thus, the modulatory role of MBL, MASPS-2 and 
downstream complement activation may suggest MASP-2 for therapeutic purpose. Further 
 22




Intraperitoneal injection of serum resistant N. gonorrhoeae pre-incubated with C1q shows a 
progressive increase in the infection (6-7 days) in an animal model of gonococcal bacteremia 
in rat pups (Nowicki et al., 1995). C1q is considered to be involved in clearance of apoptotic 
debris caused by infection during early pregnancy due to its presence at the feto-maternal 
interface in decidual endothelial cells (DEC) and trophoblast (Bulla et al., 2008) in normal 
pregnancy and PE (Lokki et al., 2014). Besides C1q, expression of MYD88, MD2, and TLR-
4 on DEC also contributes to an anti-inflammatory response at the feto-maternal interface 
(Masat et al., 2012). This makes C1q an attractive host defence molecule at the feto-maternal 
interface. Pathogens like Trypanosoma cruzi spread to humans by blood sucking bug 
Triatominae. It can also infect the decidua (trans-placental) by entering the mother through 
placenta and chorioamniotic membrane (Shippey et al, 2005). Once T. cruzi is in contact with 
the host, T. cruzi calreticulin protein (TcCRT; 45 kDa) moves from the endoplasmic 
reticulum to the external surface of the parasite. Maternal C1q in the placenta recognizes and 
binds to CRT entering the host (Ramos et al., 1991). This CRT-C1q interaction prevents the 
activation of the classical pathway and enhances the spreading of T. cruzi infection (Ferreria 
et al., 2004; Molina et al., 2005). Thus, C1q has both a protective role as well as detrimental 
effect in controlling intrauterine infection. 
 
Collectins and C1q in maternal autoimmune disorders 
The most common maternal autoimmune diseases found during pregnancy are autoimmune 
thyroid disease (AITD), gestational diabetes mellitus (GDM) and rheumatoid arthritis (RA) 
that cause adverse pregnancy outcomes (Stagnaro-Green et al., 2011). 
 
Autoimmune thyroid disease (AITD) or autoimmune thyroiditis 
Autoimmune thyroid disease is characterized by the stimulation of thyroid glands to secrete 
more thyroid hormones. The stimulation is due to specific thyroid autoantibodies, thyroid 
peroxidase (TPO) antibodies (Smallridge et al., 2000). Generally, the presence of maternal 
TPO antibodies results in neurophysiological dysfunction at the early stages (Pop et al., 
1995). In a study of pregnant women, serum MBL level was lower during first trimester and 
decreased further after delivery in thyroid dysfunction women than in normal controls. On 
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the other hand, women who reported to have an increased serum MBL level during first 
trimester had significantly decreased MBL levels after delivery (Potlukova et al., 2013). It is 
known that thyroid dysfunction influences the MBL level during pregnancy; consequently the 
association of MBL deficiency with thyroid dysfunction and the outcome of pregnancy have 
not yet been explained.  
 
Gestational diabetes mellitus (GDM)  
The primary cause for GDM is the glucose intolerance during pregnancy mainly due to 
pancreatic β-cell damage.  Tissue damage is caused by the autoantibodies against β-cell of 
the pancreas. MBL level in both diabetic and healthy women during pregnancy are decreased 
(Pertyńska et al., 2001). Subsequent study by same group showed no significant increase in 
MBL levels in diabetics and healthy pregnant women. But later, statistically significant 
differences in MBL levels between early and late trimesters in diabetics and healthy pregnant 
women were observed (Pertyńska et al., 2009). Women with low plasma MBL level and gene 
polymorphism in MBL2 (G54D) gene have higher risk of developing GDM in second or 
third trimesters of pregnancy when compared to R52C mutation (Megia et al., 2004). 
However, levels of MBL level during different gestational stages of pregnancy have not yet 
been definitively demonstrated in vivo. 
 
Rheumatoid arthritis (RA)  
It is a chronic systemic disease of the joints characterized by the inflammatory changes in the 
synovial membrane, articular structures and atrophy of bones. During pregnancy, MBL 
recognizes/binds to agalactosyl IgG and activates the complement system. By doing so it 
clears the autoantibodies (IgG) and recruitment of inflammatory cells associated with RA. 
Thus, the level of agalactosyl IgG is decreased while galactosylation is believed to improve 
pregnancy associated RA disease condition (van de Gejin et al., 2009). Postpartum decrease 
in IgG galactosylation and MBL leads to outburst of RA disease (Malhotra et al., 1995). The 
study by van de Gejin et al. provided further evidence of the dual function of MBL in 
pregnancy; firstly, on the role of MBL-2 clearing the pathogenic agalactosyl IgG, and 
secondly, its link with the pathogenesis of RA. Despite their relevance in defence 
mechanism, MBL genotype has no association with RA disease activity or modification of 
IgG galactosylation during pregnancy and after delivery (van de Gejin et al., 2011). The 
studies described above outline the delicate role of MBL exerted during pregnancy-associated 
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autoimmune diseases. Their role possibly differs depending on the polymorphism and the 
type of autoimmune disease. 
 
Conclusion 
Collectins and C1q are implicated in the immune-cross talk at the feto-maternal interface. 
Although they appear to increase progressively in the gestational tissues with advancing 
gestational age, their overall role in pregnancy maintenance and parturition, specific 
functions at different gestational age is not yet clear in normal and abnormal pregnancy. 
However, due to their ability to exhibit dual role (protective and detrimental), assigning 
specific role for each protein in pregnancy is difficult. Hence, further investigations are 
required to understand the direct cellular and regulatory roles played by collectins and C1q in 
normal pregnancy. Moreover, events in pregnancy are species-specific; the availability of 
animal models (gene deficient or over expressing) will enable to gain further insight into the 
role of soluble immune proteins in pregnancy.  The presence of SP-A, SP-D and C1q in early 
human decidua offers certain clues to future research aimed at their role in immune tolerance, 
implantation, angiogenesis, trophoblast invasion and tissue remodeling. Apoptosis 
(inflammatory condition) and the removal of apoptotic cells (anti-inflammatory condition) is 
a normal vital process taking place throughout pregnancy.  The role played by collectins and 
C1q in the clearance of the apoptotic cells during trophoblast invasion of early pregnancy and 
during parturition is a novel area for further investigation. Studies on SP-A and SP-D 
polymorphism and structural variants in association with pregnancy need to be investigated. 
Such studies will help us generate new hypothesis to identify key mechanism inducing 
immunotolerance. Evaluating the biological significance of C-type lectins in 
uterine/myometrial contraction, and cervical ripening that triggers contraction will provide us 
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Figure 1: Participation of SP-A, SP-D, MBL and C1q in pregnancy. Processes denoted in 
black are reported, processes denoted with red asterisks (*) are specific functions of SP-A 
and C1q while this has not been seen with SP-D and MBL, and processes denoted in red are 
not yet known but possible functional properties of soluble defense collagens being expressed 
during pregnancy. 
 
Figure 2: Expression of collectins and C1q in non-pregnant uterus 
 
Figure 3: Expression of collectins and C1q in pregnant uterus 
 
Figure 4: Immunofluorescent triple staining of CK-7, PU.1 and C1q in early human decidua. 
Decidual cells were fixed and permeabilized before incubating with primary and secondary 
antibodies against CK-7, PU.1, C1q or their corresponding control isotype. (A)-(C) Image of 
three different decidual samples showing the immunolocalization of CK-7 (AMCA, blue 
channel), PU.1 (cy3, red channel), and C1q (FITC, green channel), and composite (merge). 
(D) Isotype matched controls. 
 
Figure 5: Expression of SP-A1, SP-A2, SP-D, C1qA, C1qB, C1qC in human decidua. 
Human decidual samples were collected from healthy women undergoing elective 
termination of pregnancy or during labor. Informed and written consent for research 
participation was obtained from each patient through procedures approved by National 
University Health System and National University of Singapore’s Domain Specific Review 
Boards. Results are representative of two independent experiment performed in triplicate. 
Values are shown as mean ± standard error of the mean. 
 
(A) Expression of SP-A1, SP-A2, SP-D, C1q A, C1q B, and C1q C in human decidua 
obtained from women undergoing elective termination of pregnancy during first trimester. 
7+6: 7 weeks and 6 days of gestation; 8+2 : Average of 5 samples of 8
 
weeks and 2 days of 
gestation; 8+6: 8 weeks and 6 days of gestation; 9+0: Average of 2 samples of 9 weeks of 
gestation; 9+2: 9 weeks and 2 days of gestation; 9+5: 9 weeks and 5 days of gestation; 10+3: 
10 weeks and 3 days of gestation.  
 
(B) Expression of SP-A1, SP-A2, SP-D, C1q A, C1q B, and C1q C in human decidua 
obtained from women undergoing elective termination of pregnancy during first trimester and 
from women undergoing labor with a previous history of miscarriages. 8+4 (8 weeks and 4 
days of gestation) with 1 previous miscarriage, 9+4 (9 weeks and 4 days of gestation) with 
RPL with 4 previous miscarriages; 39+1 (39 weeks and 1 day of gestation) had RPL with 2 
previous miscarriages; Caesarean section (CS) with 2 previous miscarriages; lower segment 
caesarean section (LSCS) with 2 previous miscarriages. 
 
Figure 6: Animal studies showing the anti-inflammatory (protective) and pro-inflammatory 
(detrimental) role of SP-A in pregnancy and parturition. 
 








Table 1: Gene organization and function of SP-A, SP-D, MBL and C1q 
 
 









SFTPA 10q21-q24 26-35 23* Lungs No 
SFTPD 10q23-q23 43 59 Lungs No 
MBL 10q11.2-q21 28-32 19* Liver Yes 
C1q 1p34.1-1p36.3 32-40 23*  Liver Yes 
 
* Interrupted triplets by kink (no.). SP-A : GEMPCPP (13); MBL: GGTGQ (8); C1q A:GIRT 
(10); C1q C: GIPAIK (11). 
 
 
Table 2: Tissue distribution of SP-A, SP-D, MBL and C1q in gestational and non-gestational 
tissues 
 
Proteins Non gestational tissues Gestational tissues 
SP-A Lungs: alveolar type II cells, Clara 
cells, trachea, mesothelial tissues, 
synovial cells, gastrointestinal tract, 
pancreas, thymus, small intestine, 
colon, peritoneal wall, bile 
Amniotic fluid, amniotic epithelial cells, 
vaginal epithelium, vaginal lavage, uterus, 
ovary, amnion, chorion, fetal membrane, 
decidua, decidual stromal cells, trophoblast, 
placenta, placental villi,  
SP-D Lungs: alveolar type II cells, Clara 
cells, trachea, mesothelial tissues, 
synovial cells, gastrointestinal tract, 
pancreas, small intestine, brain, 
salivary gland, heart, kidney 
Amniotic fluid, amniotic epithelial cells, 
vagina, uterus, ovary, oviduct, fallopian tube, 
endometrium, fetal membrane, placenta,  
decidua, trophoblast, decidual stromal cells, 
placental villi,  
MBL Liver: hepatocytes, monocyte-derived 
dendritic cells; Kidney, Small 
intestine: epithelial cells, lymphoid and 
non- lymphoid organs and tissues 
Amniotic fluid, vaginal epithelial cells 
C1q Liver, monocytes, macrophages, 
epithelial cells, mesenchymal cells, 
dendritic cells, microglial cells, 
fibroblasts. 
Placenta, Fetal vessels, spiral arteries, 
trophoblasts, decidual stromal cells, decidual 
endothelial cells 
 
     
Table 3: Levels of SP-A, SP-D, MBL and C1q in amniotic fluid during mid and term 
pregnancy 
 
Proteins Amniotic fluid 
      Mid pregnancy Term pregnancy  
SP-A Not expressed 30-31
st
 week: 3 μg/ml   
40-41
st
 week: 24 µg/ml  
39
th
 week : 4978 µg/ml  
Term no labor : 2.2-15 µg/ml   
Term with labor: 1.2-10 µg/ml  
SP-D 14-16
th
 week: 0.11 µg/ml  38th and 42nd week: 26.3 µg/ml  
39
th
 week: 793 µg/ml  
MBL     Not known  Before 35
th
 week: 304 µg/ml  
After 35
th
 week: 1070 µg/ml 






































































































































































Figure 7: Madhukaran et al 
